CSGH yields 20000000.00% · JNJ yields 2.14%● Live data
📍 CSGH pulled ahead of the other in Year 1
Combined, CSGH + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSGH + JNJ for your $10,000?
China Sun Group High-Tech Co., through its subsidiary, Dalian Xinyang High-Tech Development Co. Ltd., engages in the production and sale of cobaltosic oxide and lithium cobalt oxide used in lithium ion rechargeable batteries in the People's Republic of China and internationally. It provides battery level cobaltosic oxide, a cathode material used in the manufacturing of lithium cobalt oxide; and lithium iron phosphate, a cathode material used in lithium iron phosphate batteries. The company also offers ternary cathode material, which is applied as the main cathodes of small-sized communication and power instruments, such as portable power tools, electronic apparatus, laptops, and video cameras, as well as electric autos and bicycles. It serves lithium ion battery manufacturers, end product users, and lithium series product manufacturers. The company was formerly known as Capital Resource Funding, Inc. and changed its name to China Sun Group High-Tech Co. in August 2007. China Sun Group High-Tech Co. is headquartered in Dalian, the People's Republic of China.
Full CSGH Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.